-
2024Genetic differentiation of Plasmodium vivax duffy binding protein in Ethiopia and comparison with other geographical isolates., Malar J 2024 Feb; 23(1): 55.
-
2024Drug-induced stress mediates Plasmodium falciparum ring-stage growth arrest and reduces in vitro parasite susceptibility to artemisinin., Microbiol Spectr 2024 Feb; (): e0350023.
-
2024Plasmodium falciparum ring-stage plasticity and drug resistance., Trends Parasitol 2024 Feb; 40(2): 118-130.
-
2023Artemisinin-Resistant HRP2-Negative Malaria in Eritrea. Reply., N Engl J Med 2023 Dec; 389(26): 2497-2498.
-
2023Unveiling P. vivax invasion pathways in Duffy-negative individuals, Cell Host & Microbe, In press, ⟨10.1016/j.chom.2023.11.007⟩.
-
2023Assessing the histidine-rich protein 2/3 gene deletion in Plasmodium falciparum isolates from Burkina Faso., Malar J 2023 Nov; 22(1): 363.
-
2023Prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation., Lancet Glob Health 2023 Nov; 11(11): e1765-e1774.
-
2023Malaria in the horn of Africa: The ongoing battle against drug resistance., Clin Transl Med 2023 Nov; 13(11): e1482.
-
2023Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea, New England Journal of Medicine, 2023, 389 (13), pp.1191-1202. ⟨10.1056/NEJMoa2210956⟩.
-
2023Polymorphism analysis of drug resistance markers in Plasmodium falciparum isolates from Benin., Acta Trop 2023 Sep; 245(): 106975.
-
2023Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance., Malar J 2023 Aug; 22(1): 240.
-
2023Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso., Malar J 2023 Jul; 22(1): 213.
-
2023Reduced polymorphism of Plasmodium vivax early transcribed membrane protein (PvETRAMP) 11.2., Parasit Vectors 2023 Jul; 16(1): 238.
-
2023Potential hidden Plasmodium vivax malaria reservoirs from low parasitemia Duffy-negative Ethiopians: Molecular evidence., PLoS Negl Trop Dis 2023 Jul; 17(7): e0011326.
-
2023Significant number of Plasmodium vivax mono-infections by PCR misidentified as mixed infections (P. vivax/P. falciparum) by microscopy and rapid diagnostic tests: malaria diagnostic challenges in Ethiopia., Malar J 2023 Jul; 22(1): 201.
-
2023Ex vivo RSA and pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017., Malar J 2023 May; 22(1): 167.
-
2023Modified Plasmodium falciparum Ring-Stage Survival Assay with ML10 Kinase Inhibitor., Antimicrob Agents Chemother 2023 May; 67(5): e0001723.
-
2023Differential transmissibility to Anopheles arabiensis of Plasmodium vivax gametocytes in patients with diverse Duffy blood group genotypes., Malar J 2023 Apr; 22(1): 136.
-
2023Ring-stage growth arrest: Metabolic basis of artemisinin tolerance in Plasmodium falciparum., iScience 2023 Jan; 26(1): 105725.
-
2022Plasmodium vivax blood stage invasion pathways: Contribution of omics technologies in deciphering molecular and cellular mechanisms., C R Biol 2022 Dec; 345(2): 91-133.
-
2022Genetic Variants of Glucose-6-Phosphate Dehydrogenase and Their Associated Enzyme Activity: A Systematic Review and Meta-Analysis., Pathogens 2022 Sep; 11(9): .
-
2022Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review., Malar J 2022 Sep; 21(1): 259.
-
2022Vivax malaria in Duffy-negative patients shows invariably low asexual parasitaemia: implication towards malaria control in Ethiopia., Malar J 2022 Aug; 21(1): 230.
-
2022Human peroxiredoxin 6 is essential for malaria parasites and provides a host-based drug target., Cell Rep 2022 Jun; 39(11): 110923.
-
2022Pfkelch13 Plasmodium falciparum Mutations in Huambo, Angola., Pathogens 2022 May; 11(5): .
-
2022Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers., Malar J 2022 Apr; 21(1): 134.
-
2022Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data., BMC Med 2022 Mar; 20(1): 85.
-
2022Repeatability and reproducibility of a handheld quantitative G6PD diagnostic., PLoS Negl Trop Dis 2022 Feb; 16(2): e0010174.
-
2022Repeatability and reproducibility of a handheld quantitative G6PD diagnostic., PLoS Negl Trop Dis 2022 Feb; 16(2): e0010174.
-
2021Compensating P. falciparum artemisinin resistance., Cell Host Microbe 2021 12; 29(12): 1732-1734.
-
2021Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria., Malar J 2021 Sep; 20(1): 366.
-
2021Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria., PLoS Negl Trop Dis 2021 Sep; 15(9): e0009690.
-
2021A genetic intervention., Elife 2021 Aug; 10(): .
-
2021Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness., Elife 2021 Jul; 10(): .
-
2021Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine and polymorphism in Plasmodium falciparum kelch13-propeller gene in Equatorial Guinea., Malar J 2021 Jun; 20(1): 275.
-
2021Genetic diversity of Plasmodium falciparum populations in three malaria transmission settings in Madagascar., Malar J 2021 May; 20(1): 239.
-
2021Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017-2018., Malar J 2021 Jan; 20(1): 48.
-
2021Hyperendemicity of cysticercosis in Madagascar: Novel insights from school children population-based antigen prevalence study., PLoS One 2021 ; 16(10): e0258035.
-
2020Towards harmonization of microscopy methods for malaria clinical research studies., Malar. J. 2020 Sep; 19(1): 324.
-
2020RIFINing Plasmodium-NK Cell Interaction., Trends Parasitol. 2020 Aug; (): .
-
2020Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda., Nat. Med. 2020 Aug; (): .
-
2020Knowing the enemy: genetics to track antimalarial resistance., Lancet Infect Dis 2020 Jul; (): .
-
2020Keep the quality high: the benefits of lot testing for the quality control of malaria rapid diagnostic tests., Malar. J. 2020 Jul; 19(1): 247.
-
2020Molecular assessment of kelch13 non-synonymous mutations in Plasmodium falciparum isolates from Central African Republic (2017-2019)., Malar J 2020 May; 19(1): 191.
-
2020Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis., PLoS Med. 2020 05; 17(5): e1003084.
-
2020WHO malaria nucleic acid amplification test external quality assessment scheme: results of distribution programmes one to three., Malar J 2020 Mar; 19(1): 129.
-
2020Significant efficacy of single low dose primaquine compared to stand alone artemisinin combination therapy in reducing gametocyte carriage in Cambodian patients with uncomplicated multidrug resistant malaria, Antimicrob. Agents Chemother. 2020 Mar;.
-
2020Effect of mass dihydroartemisinin-piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance., PLoS One 2020 ; 15(10): e0240174.
-
2019Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis, PLoS Med. 2019 Dec;16(12):e1002992.
-
2019A review of the WHO malaria rapid diagnostic test product testing programme (2008-2018): performance, procurement and policy, Malar. J. 2019 Dec;18(1):387.
-
2019In vitro activity of ferroquine against artemisinin-based combination therapy (ACT)-resistant Plasmodium falciparum isolates from Cambodia, J. Antimicrob. Chemother. 2019 Nov;74(11):3240-3244.
-
2019Plasmodium falciparum resistance to piperaquine driven by PfCRT, Lancet Infect Dis 2019 Nov;19(11):1168-1169.
-
2019Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency, J. Infect. Dis. 2019 Sep;.
-
2019Accelerated evolution and spread of multidrug-resistant Plasmodium falciparum takes down the latest first-line antimalarial drug in southeast Asia, Lancet Infect Dis 2019 Jul;.
-
2019Improving methods for analysing anti-malarial drug efficacy trials: molecular correction based on length-polymorphic markers , and, Antimicrob. Agents Chemother. 2019 Jul;.
-
2019Households or hotspots? Defining intervention targets for malaria elimination in Ratanakiri Province, eastern Cambodia, J. Infect. Dis. 2019 Apr;.
-
2019African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker, Malar. J. 2019 Apr;18(1):126.
-
2019The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians, BMC Infect. Dis. 2019 Mar;19(1):250.
-
2019Lack of quadruple and quintuple mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates from Brazilian endemic areas, Mem. Inst. Oswaldo Cruz 2019 Feb;114:e180425.
-
2019Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion, Malar. J. 2019 Jan;18(1):20.
-
2019Plasmodium vivax transcriptomes reveal stage-specific chloroquine response and differential regulation of male and female gametocytes, Nat Commun 2019 Jan;10(1):371.
-
2019An Update on Artemisinin Resistance, Methods Mol. Biol. 2019;2013:141-149.
-
2018Asymptomatic infections among Duffy-negative population in Kedougou, Senegal, Trop Med Health 2018;46:45.
-
2018Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania, Malar. J. 2018 Oct;17(1):369.
-
2018Genetic diversity in two Plasmodium vivax protein ligands for reticulocyte invasion., 2018 10; 12(10): e0006555.
-
2018Therapeutic and Transmission-Blocking Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia, Emerging Infect. Dis. 2018 Aug;24(8):1516-1519.
-
2018Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine, Nat Commun 2018 Aug;9(1):3314.
-
2018Recrudescence, reinfection or relapse? A more rigorous framework to assess chloroquine efficacy for vivax malaria, J. Infect. Dis. 2018 Aug;.
-
2018Importance of household-level risk factors in explaining micro-epidemiology of asymptomatic malaria infections in Ratanakiri Province, Cambodia, Sci Rep 2018 Aug;8(1):11643.
-
2018Absence of K13 Polymorphism in Parasites from Brazilian Endemic Areas, Antimicrob. Agents Chemother. 2018 Jul;.
-
2018Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax., 2018 Jul; 8(1): 10511.
-
2018Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone, Acta Trop. 2018 Jun;185:363-370.
-
2018Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals, Malar. J. 2018 Jun;17(1):218.
-
2018Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum, Nat Commun 2018 May;9(1):1769.
-
2018A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants, Malar. J. 2018 Apr;17(1):175.
-
2018Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape, Malar. J. 2018 Feb;17(1):75.
-
2018Multidrug-resistant Plasmodium falciparum malaria in the Greater Mekong subregion, Lancet Infect Dis 2018 Feb;.
-
2018Contribution to malaria transmission of symptomatic and asymptomatic parasite carriers in Cambodia, J. Infect. Dis. 2018 Jan;.
-
2018Genomic Analyses Reveal the Common Occurrence and Complexity of Plasmodium vivax Relapses in Cambodia, MBio 2018 Jan;9(1).
-
2018Closing in on the Reservoir: Proactive Case Detection in High-Risk Groups as a Strategy to Detect Plasmodium falciparum Asymptomatic Carriers in Cambodia, Clin. Infect. Dis. 2018 Jan;.
-
2018Identification and characterization of areas of high and low risk for asymptomatic malaria infections at sub-village level in Ratanakiri, Cambodia, Malar. J. 2018 Jan;17(1):27.
-
2018A Novel Single-Nucleotide Polymorphism Loop Mediated Isothermal Amplification Assay for Detection of Artemisinin-Resistant Malaria, Open Forum Infect Dis 2018 Apr;5(4):ofy011.
-
2018Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015, Emerging Infect. Dis. 2018 01;24(1):40-48.
-
2017Functional analysis of Plasmodium falciparum subpopulations associated with artemisinin resistance in Cambodia, Malar. J. 2017 Dec;16(1):493.
-
2017Emergence of Plasmodium falciparum triple mutant in Cambodia, Lancet Infect Dis 2017 Dec;17(12):1233.
-
2017Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism, J. Antimicrob. Chemother. 2017 Nov;.
-
2017Performance of Rapid Diagnostic Testing in Patients with Suspected Malaria in Cambodia, a Low-Endemicity Country Aiming for Malaria Elimination, Clin. Infect. Dis. 2017 Oct;65(10):1769-1770.
-
2017Prevalence of K13 mutation and Day-3 positive parasitaemia in artemisinin-resistant malaria endemic area of Cambodia: a cross-sectional study, Malar. J. 2017 Sep;16(1):372.
-
2017Adapting reactive case detection strategies for falciparum malaria in a low-transmission area in Cambodia, Clin. Infect. Dis. 2017 Sep;.
-
2017Characterization of P. vivax blood stage transcriptomes from field isolates reveals similarities among infections and complex gene isoforms, Sci Rep 2017 Aug;7(1):7761.
-
2017Antimalarial Drug Resistance: A Threat to Malaria Elimination, Cold Spring Harb Perspect Med 2017 Jul;7(7).
-
2017Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam, Emerging Infect. Dis. 2017 04;23(4):715-717.
-
2017Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa, N. Engl. J. Med. 2017 03;376(10):991-3.
-
2017Modelling primaquine-induced haemolysis in G6PD deficiency, Elife 2017 02;6.
-
2017The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study, Lancet Infect Dis 2017 May;17(5):491-497.
-
2016Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana., Malar J 2016 Nov; 15(1): 540.
-
2016Serological markers to measure recent changes in malaria at population level in Cambodia, Malar. J. 2016 Nov;15(1):529.
-
2016A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study, Lancet Infect Dis 2017 Feb;17(2):174-183.
-
2016An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia, BMC Med 2016 Oct;14(1):171.
-
2016Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia, Int J Health Geogr 2016 10;15(1):37.
-
2016Geographical patterns of malaria transmission based on serological markers for falciparum and vivax malaria in Ratanakiri, Cambodia, Malar. J. 2016 Oct;15(1):510.
-
2016Plasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia, Am. J. Trop. Med. Hyg. 2016 Dec;95(6):1228-1238.
-
2016Plasmodium vivax Malaria in Cambodia, Am. J. Trop. Med. Hyg. 2016 Dec;95(6 Suppl):97-107.
-
2016Role of K13 Mutations in Artemisinin-Based Combination Therapy, Clin. Infect. Dis. 2016 Dec;63(12):1680-1681.
-
2016Artemisinin-Resistant Plasmodium falciparum K13 Mutant Alleles, Thailand-Myanmar Border, Emerging Infect. Dis. 2016 08;22(8):1503-5.
-
2016National Malaria Prevalence in Cambodia: Microscopy Versus Polymerase Chain Reaction Estimates, Am. J. Trop. Med. Hyg. 2016 Sep;95(3):588-94.
-
2016Efficacy of topical mosquito repellent (picaridin) plus long-lasting insecticidal nets versus long-lasting insecticidal nets alone for control of malaria: a cluster randomised controlled trial, Lancet Infect Dis 2016 Oct;16(10):1169-1177.
-
2016A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms., N Engl J Med 2016 Jun; 374(25): 2453-64.
-
2016Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia, Antimicrob. Agents Chemother. 2016 Jul;60(7):3884-90.
-
2016Plasmodium falciparum parasite population structure and gene flow associated to anti-malarial drugs resistance in Cambodia, Malar. J. 2016 06;15:319.
-
2016Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola, Malar. J. 2016 06;15:309.
-
2016Identification and Characterization of Two Novel RNA Viruses from Anopheles gambiae Species Complex Mosquitoes, PLoS ONE 2016;11(5):e0153881.
-
2016Plasmodium copy number variation scan: gene copy numbers evaluation in haploid genomes, Malar. J. 2016 Apr;15:206.
-
2016[Multiple and successive treatment failures in a patient infected by Plasmodium falciparum in Cambodia and treated by dihydroartemisinin-piperaquine], Bull Soc Pathol Exot 2016 May;109(2):87-90.
-
2016Complexity of Infection and Genetic Diversity in Cambodian Plasmodium vivax, PLoS Negl Trop Dis 2016 Mar;10(3):e0004526.
-
2016Reactive case-detection of malaria in Pailin Province, Western Cambodia: lessons from a year-long evaluation in a pre-elimination setting, Malar. J. 2016 Mar;15:132.
-
2016Plasmodium vivax mdr1 genotypes in isolates from successfully cured patients living in endemic and non-endemic Brazilian areas, Malar. J. 2016 Feb;15:96.
-
2015Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations, BMC Med 2015 Dec;13:305.
-
2015Challenges in Antimalarial Drug Treatment for Vivax Malaria Control, Trends Mol Med 2015 Dec;21(12):776-88.
-
2015K13-Propeller Polymorphisms in Plasmodium falciparum Isolates from Patients in Mayotte in 2013 and 2014, Antimicrob. Agents Chemother. 2015 Dec;59(12):7878-81.
-
2015Novel Cross-Border Approaches to Optimise Identification of Asymptomatic and Artemisinin-Resistant Plasmodium Infection in Mobile Populations Crossing Cambodian Borders, PLoS ONE 2015;10(9):e0124300.
-
2015Implementation and application of a multiplex assay to detect malaria-specific antibodies: a promising tool for assessing malaria transmission in Southeast Asian pre-elimination areas, Malar. J. 2015 Sep;14:338.
-
2015Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency, BMC Med 2015 Aug;13:203.
-
2015Plasmodium vivax Diversity and Population Structure across Four Continents, PLoS Negl Trop Dis 2015;9(6):e0003872.
-
2015Use of Plasmodium falciparum culture-adapted field isolates for in vitro exflagellation-blocking assay., Malar J 2015 Jun; 14(): 234.
-
2015Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment, Antimicrob. Agents Chemother. 2015 Aug;59(8):4719-26.
-
2015The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data, BMC Med 2015 Mar;13:66.
-
2015Malaria rapid diagnostic test as point-of-care test: study protocol for evaluating the VIKIA Malaria Ag Pf/Pan, Malar. J. 2015 Mar;14:114.
-
2015Towards real-time monitoring of artemisinin resistance, Lancet Infect Dis 2015 Apr;15(4):367-8.
-
2015Malaria PCR detection in Cambodian low-transmission settings: dried blood spots versus venous blood samples, Am. J. Trop. Med. Hyg. 2015 Mar;92(3):573-7.
-
2014Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia, PLoS ONE 2014;9(12):e116143.
-
2014Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates, Science 2015 Jan;347(6220):428-31.
-
2014Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013, Malar. J. 2014 Dec;13:472.
-
2014Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans, Antimicrob. Agents Chemother. 2015 Feb;59(2):950-9.
-
2014Reduced polymorphism in the Kelch propeller domain in Plasmodium vivax isolates from Cambodia, Antimicrob. Agents Chemother. 2015 Jan;59(1):730-3.
-
2014Plasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study, Malar. J. 2014 Oct;13:394.
-
2014Effects of mefloquine use on Plasmodium vivax multidrug resistance., Emerg Infect Dis 2014 Oct; 20(10): 1637-44.
-
2014Spatial clustering and risk factors of malaria infections in Ratanakiri Province, Cambodia, Malar. J. 2014 Sep;13:387.
-
2014Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia, J. Infect. Dis. 2015 Mar;211(5):670-9.
-
2014[Towards a better understanding of the molecular mechanisms of P. falciparum resistance to artemisinin], Med Sci (Paris) 2014 Aug-Sep;30(8-9):727-9.
-
2014Genetic diversity and population structure of Plasmodium vivax isolates from Sudan, Madagascar, French Guiana and Armenia, Infect. Genet. Evol. 2014 Oct;27:244-9.
-
2014Molecular surveillance for artemisinin resistance in Africa, Lancet Infect Dis 2014 Aug;14(8):668-670.
-
2014Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine, Am. J. Trop. Med. Hyg. 2014 Oct;91(4):833-43.
-
2014Artemisinin resistance in Plasmodium falciparum, Lancet Infect Dis 2014 Jun;14(6):449-50.
-
2014Plasmodium falciparum founder populations in western Cambodia have reduced artemisinin sensitivity in vitro, Antimicrob. Agents Chemother. 2014 Aug;58(8):4935-7.
-
2014Acute undifferentiated febrile illness in rural Cambodia: a 3-year prospective observational study, PLoS ONE 2014;9(4):e95868.
-
2014Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria, Infect. Genet. Evol. 2014 Jul;25:81-92.
-
2014Patterns of selection on Plasmodium falciparum erythrocyte-binding antigens after the colonization of the New World., Mol Ecol 2014 Apr; 23(8): 1979-93.
-
2013A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature 2014 Jan;505(7481):50-5.
-
2013De novo assembly of a field isolate genome reveals novel Plasmodium vivax erythrocyte invasion genes, PLoS Negl Trop Dis 2013;7(12):e2569.
-
2013Injections, cocktails and diviners: therapeutic flexibility in the context of malaria elimination and drug resistance in Northeast Cambodia, PLoS ONE 2013;8(11):e80343.
-
2013An innovative tool for moving malaria PCR detection of parasite reservoir into the field, Malar. J. 2013 Nov;12:405.
-
2013G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests, Malar. J. 2013 Nov;12:391.
-
2013Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains., PLoS Negl Trop Dis 2013 Nov; 7(11): e2489.
-
2013Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia, Malar. J. 2013 Sep;12:343.
-
2013Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies, Lancet Infect Dis 2013 Dec;13(12):1043-9.
-
2013Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers, Antimicrob. Agents Chemother. 2013 Nov;57(11):5277-83.
-
2013[Plasmodium falciparum susceptibility to antimalarial drugs: global data issued from the Pasteur Institutes international network], Med Sci (Paris) 2013 Jun-Jul;29(6-7):647-55.
-
2013High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool., Antimicrob Agents Chemother 2013 Jul; 57(7): 3121-30.
-
2013The evolutionary history of Plasmodium vivax as inferred from mitochondrial genomes: parasite genetic diversity in the Americas, Mol. Biol. Evol. 2013 Sep;30(9):2050-64.
-
2013G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients, Malar. J. 2013 May;12:171.
-
2013In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound, J. Biol. Chem. 2013 Jun;288(25):18561-73.
-
2013Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report, Malar. J. 2013 Mar;12:112.
-
2012Plasmodium falciparum Na+/H+ exchanger (pfnhe-1) genetic polymorphism in Indian Ocean malaria-endemic areas, Am. J. Trop. Med. Hyg. 2013 Jan;88(1):37-42.
-
2012Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia, Antimicrob. Agents Chemother. 2013 Feb;57(2):914-23.
-
2012Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010, Antimicrob. Agents Chemother. 2013 Feb;57(2):818-26.
-
2012Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria, Clin. Infect. Dis. 2013 Mar;56(5):e48-58.
-
2012Global analysis of Plasmodium falciparum Na(+)/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinine, Int J Parasitol Drugs Drug Resist 2013 Dec;3:8-19.
-
2012Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia, PLoS ONE 2012;7(10):e45797.
-
2012Whole genome sequencing of field isolates provides robust characterization of genetic diversity in Plasmodium vivax, PLoS Negl Trop Dis 2012;6(9):e1811.
-
2012Mapping the aetiology of non-malarial febrile illness in Southeast Asia through a systematic review–terra incognita impairing treatment policies, PLoS ONE 2012;7(9):e44269.
-
2012Performance of “VIKIA Malaria Ag Pf/Pan” (IMACCESS®), a new malaria rapid diagnostic test for detection of symptomatic malaria infections, Malar. J. 2012 Aug;11:295.
-
2012Management of uncomplicated malaria in febrile under five-year-old children by community health workers in Madagascar: reliability of malaria rapid diagnostic tests, Malar. J. 2012 Mar;11:85.
-
2012Compliance, safety, and effectiveness of fixed-dose artesunate-amodiaquine for presumptive treatment of non-severe malaria in the context of home management of malaria in Madagascar, Am. J. Trop. Med. Hyg. 2012 Feb;86(2):203-10.
-
2012Individual Plasmodium vivax msp1 variants within polyclonal P. vivax infections display different propensities for relapse, J. Clin. Microbiol. 2012 Apr;50(4):1449-51.
-
2012Multiple independent introductions of Plasmodium falciparum in South America., Proc Natl Acad Sci U S A 2012 Jan; 109(2): 511-6.
-
2011Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening, PLoS ONE 2011;6(12):e28357.
-
2011Reduced impact of pyrimethamine drug pressure on Plasmodium malariae dihydrofolate reductase gene, Antimicrob. Agents Chemother. 2012 Feb;56(2):863-8.
-
2011Plasmodium knowlesi infection in humans, Cambodia, 2007-2010, Emerging Infect. Dis. 2011 Oct;17(10):1900-2.
-
2011In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum, Malar. J. 2011 Sep;10:283.
-
2011[Resistance of Plasmodium falciparum to antimalarial drugs: impact on malaria pre-elimination in Madagascar], Med Trop (Mars) 2011 Jun;71(3):298-304.
-
2011The global distribution of the Duffy blood group, Nat Commun 2011;2:266.
-
2010Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar, PLoS ONE 2010 Oct;5(10):e13281.
-
2010Plasmodium vivax and the Duffy antigen: a paradigm revisited, Transfus Clin Biol 2010 Sep;17(3):176-83.
-
2010Heritability of the human infectious reservoir of malaria parasites, PLoS ONE 2010 Jun;5(6):e11358.
-
2010OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic, BMC Res Notes 2010 May;3:136.
-
2010Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests, Malar. J. 2010 May;9:129.
-
2010Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa, Am. J. Trop. Med. Hyg. 2010 May;82(5):782-7.
-
2010Origins of the recent emergence of Plasmodium falciparum pyrimethamine resistance alleles in Madagascar, Antimicrob. Agents Chemother. 2010 Jun;54(6):2323-9.
-
2010Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people, Proc. Natl. Acad. Sci. U.S.A. 2010 Mar;107(13):5967-71.
-
2010History and current status of Plasmodium falciparum antimalarial drug resistance in Madagascar, Scand. J. Infect. Dis. 2010;42(1):22-32.
-
2009Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility, Antimicrob. Agents Chemother. 2009 Nov;53(11):4588-97.
-
2009High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana., Am J Trop Med Hyg 2009 Jul; 81(1): 19-22.
-
2009Rapid detection of point mutations in Plasmodium falciparum genes associated with antimalarial drugs resistance by using High-Resolution Melting analysis, J. Microbiol. Methods 2009 Aug;78(2):165-70.
-
2009Epidemiological situation of malaria in Madagascar: baseline data for monitoring the impact of malaria control programmes using serological markers, Acta Trop. 2009 Aug;111(2):160-7.
-
2008Evaluation of two new immunochromatographic assays for diagnosis of malaria, Am. J. Trop. Med. Hyg. 2008 Nov;79(5):670-2.
-
2008Country-wide assessment of the genetic polymorphism in Plasmodium falciparum and Plasmodium vivax antigens detected with rapid diagnostic tests for malaria, Malar. J. 2008 Oct;7:219.
-
2008Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes, Antimicrob. Agents Chemother. 2008 Dec;52(12):4233-40.
-
2008Analysis of circulating populations of Plasmodium falciparum in mild and severe malaria in two different epidemiological patterns in Madagascar, Trop. Med. Int. Health 2008 Nov;13(11):1392-9.
-
2008Dihydrofolate reductase I164L mutation in Plasmodium falciparum, Madagascar, Emerging Infect. Dis. 2008 Jul;14(7):1166-7.
-
2008Genetic diversity and genotype multiplicity of Plasmodium falciparum infections in symptomatic individuals living in Bangui (CAR), Acta Trop. 2008 Jul;107(1):37-42.
-
2008Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials, Malar. J. 2008 Apr;7:55.
-
2008Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates, Trans. R. Soc. Trop. Med. Hyg. 2008 Apr;102(4):346-51.
-
2008Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine, Malar. J. 2008 Feb;7:35.
-
2008Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria-endemic countries, Am. J. Trop. Med. Hyg. 2008 Feb;78(2):217-21.
-
2007Sequence analysis of Plasmodium falciparum cytochrome b in multiple geographic sites, Malar. J. 2007 Dec;6:164.
-
2007Molecular epidemiology of wild poliovirus type 1 circulation in West and Central Africa, from 1997 to 1999, using genotyping with a restriction fragment length polymorphism assay, Arch. Virol. 2008;153(3):409-16.
-
2007Short report: prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar, Am. J. Trop. Med. Hyg. 2007 Dec;77(6):1039-42.
-
2007Drug-resistant malaria parasites introduced into Madagascar from Comoros Islands, Emerging Infect. Dis. 2007 Nov;13(11):1759-62.
-
2007Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar, Malar. J. 2007 May;6:65.
-
2007Which malaria rapid test for Madagascar? Field and laboratory evaluation of three tests and expert microscopy of samples from suspected malaria patients in Madagascar, Am. J. Trop. Med. Hyg. 2007 Mar;76(3):481-5.
-
2006Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children, Malar. J. 2006 Sep;5:79.
-
2006Polymorphisms in pfcrt, pfmdr1, dhfr genes and in vitro responses to antimalarials in Plasmodium falciparum isolates from Bangui, Central African Republic, Am. J. Trop. Med. Hyg. 2006 Sep;75(3):381-7.
-
2006Cocirculation of measles virus genotype B2 and B3.1 in Central African Republic during the 2000 measles epidemic, J. Med. Virol. 2006 Jul;78(7):964-70.
-
2006Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic, Am. J. Trop. Med. Hyg. 2006 Feb;74(2):205-10.
-
2005Efficacy of chloroquine-proguanil malaria prophylaxis in a non-immune population in Bangui, Central African Republic: a case-control study, Trans. R. Soc. Trop. Med. Hyg. 2006 Apr;100(4):381-6.
-
2005Wild poliovirus type 1, Central African Republic, Emerging Infect. Dis. 2005 Sep;11(9):1498-9.
-
2005Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment, Am. J. Trop. Med. Hyg. 2005 Aug;73(2):239-43.
-
2005Evaluation of rapid HIV testing strategies in under equipped laboratories in the Central African Republic, J. Virol. Methods 2005 Jun;126(1-2):75-80.
-
2005Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with noncomplicated malaria, Am. J. Trop. Med. Hyg. 2005 May;72(5):581-5.
-
2004HIV epidemic in Central African Republic: high prevalence rates in both rural and urban areas, J. Med. Virol. 2004 Mar;72(3):358-62.
-
2003Advantages of an alternative strategy based on consecutive HIV serological tests for detection of HIV antibodies in Central African Republic, J. Virol. Methods 2003 Aug;111(2):129-34.
-
2003Immunohematological reference ranges for adults from the Central African Republic, Clin. Diagn. Lab. Immunol. 2003 May;10(3):443-5.
-
2003Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Bangui, Central African Republic, J. Antimicrob. Chemother. 2003 Jan;51(1):192-4.
-
2002Extrapulmonary and pulmonary tuberculosis in antananarivo (madagascar): high clustering rate in female patients, J. Clin. Microbiol. 2002 Nov;40(11):3964-9.
-
2002[Results of active surveillance of acute flaccid paralysis in the Central African Republic and Chad from 1995 to 2000], Med Trop (Mars) 2002;62(1):63-9.
-
2001[Toxoplasmosis, rubella, syphilis, hepatitis B and HIV infection in women being followed for pregnancy in a population on the east coast of New Caledonia ], Bull Soc Pathol Exot 2001 Dec;94(5):403-5.
-
2000Transmission of tuberculosis in the prison of Antananarivo (Madagascar), Res. Microbiol. 2000 Nov;151(9):785-95.
-
1999[Immunoblot applied to the diagnosis of congenital toxoplasmosis], Pathol. Biol. 1999 Oct;47(8):797-804.
-
1999Prevalence of Mycobacterium bovis in human pulmonary and extra-pulmonary tuberculosis in Madagascar, Int. J. Tuberc. Lung Dis. 1999 Jul;3(7):632-4.
-
1995[Extra-pulmonary tuberculosis in Antananarivo. Principal localizations and biological diagnosis], Arch Inst Pasteur Madagascar 1995;62(1):77-82.
-
1995[Evolution of the Mycobacteria Laboratory of the Pasteur Institute of Madagascar from 1991 to 1994], Arch Inst Pasteur Madagascar 1995;62(1):52-8.
-
1994[Study of 3985 female genital smears from the Clinical Biology Center of the Pasteur Institute in Madagascar], Arch Inst Pasteur Madagascar 1994;61(2):105-7.
-
1993How to run a brain bank., J Neural Transm Suppl 1993 ; 39(): 1-246.
-
1988[Bone substitutes in tooth transplantations], Dtsch Zahnarztl Z 1988 Jan;43(1):57-60.